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Abstract
Staphylococcus aureus is a major cause of prosthetic joint infection (PJI) in which it forms
adherent biofilms, thick aggregates of extracellular polymeric substances (EPS) produced by the
bacteria. Biofilm associated infections are difficult to treat as they have increased resistance to
various antimicrobial agents, which means infected implants often require multiple procedures
and prolonged antibiotic therapy. However, a new and emerging method of treatment of PJI is
non-contact induction heating (NCIH) of metal implants. We sought to investigate the feasibility
and effectiveness of NCIH along with synergistic effects of antibiotics (Vancomycin) in reducing
bacterial load within surface associated biofilms in vitro on stainless steel and titanium washers.
Our preliminary results support the hypothesis that NCIH of metal implants is effective in
reducing bacterial load of S. aureus within a biofilm in vitro. In our study, the synergistical use
of the dual treatment strategy (heat and antibiotics) resulted in a ~1000-fold total decrease in
CFUs/ml (~3 log reduction). This suggests the potential synergistic effect between the heat and
antibiotic treatment against biofilms. These results can be further explored as a new treatment
modality for PJI and infections of orthopedic implants. Future work in this study will investigate
if NCIH can be used synergistically with antibiotics to more effectively eliminate biofilm
associated infections.
Keywords - Prosthetic joint infection (PJI), Total Joint Replacement, Induction heating, Biofilm,
Non-contact induction heating.
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Summary for Lay Audience
One of the most challenging complications after total joint replacement surgery is
periprosthetic joint infections (PJI). Staphylococcus aureus is the bacteria responsible for the
majority of these infections. One of the reasons that these infections are challenging to treat
either with antibiotics or surgically with the present standard of care practices is that the residing
bacteria form a “slime” like layer, called biofilms on the surfaces of the implants and the
adjacent periprosthetic tissue. Biofilm associated infections are difficult to treat as they have
increased resistance to various antimicrobial agents, which means infected implants often require
multiple surgical procedures and prolonged antibiotic therapy. However, a new and emerging
method of treatment of PJI is non-contact induction heating (NCIH) of metal implants. We
sought to investigate the feasibility and effectiveness of NCIH of metal implants along with
antibiotics in reducing bacterial load within surface associated biofilms in vitro. These
preliminary results support the hypothesis that NCIH of metal implants is effective in reducing
bacterial load of S. aureus within a biofilm in vitro. These results can be further explored as a
new treatment modality for PJI and infections of orthopedic implants. Future work in this study
will investigate if NCIH can be used synergistically with antibiotics to more effectively eliminate
biofilm associated infections completely.
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Chapter 1 – Introduction

1.1 Introduction to Staphylococcus aureus biofilms and infection

A biofilm is defined as a sessile microbial community in which cells are attached to a
surface or to other cells and embedded in a protective extracellular polymeric matrix (1). Biofilms
act as environmental reservoirs for pathogens, and growth within a biofilm may provide organisms
with survival advantages in natural environments and increase their virulence. Staphylococcus
aureus is a gram-positive commensal bacterium that persistently colonizes the anterior nares of
approximately 20– 25% of the healthy adult population and is the second most frequent cause of
nosocomial blood infections. Approximately 80% of nosocomial infections caused by S. aureus
are due to colonization by the same strain (2). Ellis et al.(3) report that that nasal colonization does
not appear to be the only requirement for community-associated S. aureus related infection and
other factors such as different anatomic sites, person-to-person spread, and fomites are likely
important factors as well.
S. aureus is known to cause a diverse range of acute and chronic infections. For instance,
acute bacteremia and skin abscesses, are caused by planktonic cells through the production of
secreted toxins and exoenzymes (4). Chronic infections are linked with a biofilm mode of growth
where S. aureus attaches and persist on host tissues, such as bone and heart valves, to cause
osteomyelitis and endocarditis respectively or on medical and surgical implants, such as catheters,
prosthetic joints, and pace makers (1).
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1.1.1 MRSA and CA- MRSA (USA 300)

Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of morbidity
and mortality in hospitals globally. MRSA is endemic in North America and has also been involved
in epidemiologically unassociated outbreaks of skin and soft tissue infections in healthy
individuals in at least 21 US states, Canada and Europe (8). Methicillin resistance in S. aureus is
defined as an oxacillin minimum inhibitory concentration (MIC) of greater than or equal to 4
micrograms/mL (5). Healthcare-associated MRSA infections occur in individuals with
predisposing risk factors for diseases, whereas community-associated MRSA (CA-MRSA)
infections often occur in healthy individuals. CA-MRSA infections are known to be epidemic in
some countries and are more virulent and transmissible than traditional hospital-associated MRSA
strains (6). In addition to enhanced virulence, some CA-MRSA strains such as USA300 have the
ability to spread readily (6). Ellis et al. (3) reported that USA300 MRSA colonization with MRSA
associated skin and soft tissue infection is relatively uncommon, but when it does occur, it appears
to be playing a role in pathogenesis.

1.2

Clinical significance

Biofilm associated infection is one of the most common causes for failure of orthopedic
implants and cause extensive morbidity, high cost of care, and tremendous socioeconomic burden
(7). The infection burden associated with total hip and knee arthroplasty is low, with estimates
ranging from around 1% to 2% (8). The 5-year survival rate associated with PJI (87.3%) is worse
than that of three of the most common cancers: prostate (99%), breast (89%), and melanoma(91%)
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(9). All the materials used in orthopedic implants are vulnerable to attachment of biofilm forming
bacteria, which places these implants at risk for surgical site infections (SSIs). Pathogenesis of
biofilm associated implant-related infections develops after pathogens attach to the protein
conditioned surface, which is known to occur intraoperatively, post operatively, and on a delayed
basis. Present standard of care strategies include antibiotic suppression, debridement with retention
of prosthesis (DAIR) (10, 11), excision arthroplasty including single-stage revision (11), or twostage revision (12), multiple- stage revision; partial revision (13) and arthrodesis. The reported
overall infection-free survivorship for two-stage revision TKA was 85% at 5 years and 78% at 10
years (14). More than 25% of revision surgeries are attributed to PJI and in many cases, multiple
revision surgeries for failed eradication of PJI result in amputation or death. (7)

1.2.1 Diagnostic and therapeutic challenges

Most common signs and symptoms of periprosthetic joint infection ( PJI) include local or
diffused pain, joint swelling or effusion, erythema or warmth around the joint, fever, drainage,
implant loosening or the presence of a sinus tract communicating with the joint , but a few cases
can also present with few symptoms or signs (7, 15). With currently available diagnostic tests,
clinical diagnosis can be challenging unless the dispersed microorganism is virulent enough to
incite a host response. Biofilm bacteria are challenging to diagnose because, they often do not
grow by routine culture resulting in a high false-negative rate, absence of definitive biofilm
biomarkers and absence of specific imaging modality that can directly detect biofilms (16).
Sensitivity of conventional microbiologic culture methods can be low, due to the inability of
microorganisms to propagate in the sessile phenotype. Inability to isolate and identify the causative
pathogen is not only associated with challenges in choosing the correct antimicrobials but also can
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lead to continuation of the infection and higher chances of persistence of infection following
revision surgery.

1.2.2 PJI - Periprosthetic Joint Infections
Joint replacement arthroplasty is a highly effective intervention that improves the quality
of life of the patient, relieves symptoms, restores joint function, and improves mobility and
independence in patients with severe osteoarthritis, inflammatory arthritis, post-traumatic arthritis
and many conditions that affect the articular surfaces (17). There is an increasing volume of
primary joint arthroplasties, with a projected annual volume of more than 4 million cases by 2030
in the United States. The economic burden of treating infected revisions is estimated to be$1.62
billion in the United States by2020 (18). Despite global efforts to reduce postoperative infection,
infection burden has actually increased worldwide, based on publicly reported data from 6
arthroplasty registries (8).
PJI associated with biofilms in particular, prove difficult to treat and the optimal surgical
and antibiotic treatment of PJI is unclear (19, 20). One of the reasons that these infections are so
difficult to treat by a single round of antibiotic therapy alone is that the residing bacteria form
biofilms on the surfaces of the implants and the adjacent periprosthetic tissue (21).

1.2.3 Biofilm –Pathogens forming biofilm
Bacterial biofilms can be formed by gram-positive or gram-negative, motile or nonmotile,
rapid or slow growing, and aerobic, facultative, or anaerobic species (22). All of the common
pathogens associated with PJI have been shown to form biofilm by in vitro experiments or by ex
vivo examination of retrieved components. These include the Enterococcus faecium,
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Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas
aeruginosa, and Enterobacter species as well as low-virulence pathogens such as Cutibacterium
(formerly Propionibacterium) acnes and coagulase-negative staphylococci such as Staphylococcus
epidermidis. Apart from bacteria, fungal pathogens such as Candida can also form biofilms (23).

1.3 Biofilm - Stages of development

The life cycle of biofilm is a complex continuum progressing through four stages (21): (1)
Attachment -interaction between bacteria and the implant; (2) Accumulation -interactions between
bacterial cells ,where cells on the surface begin to transition from the planktonic (free floating) to
the biofilm phenotype where they begin to produce extracellular polymeric substance (EPS) and
undergo cell division to produce small aggregates and clusters; (3) Maturation -formation of a
viable 3D structure in which the structures are large enough to develop distinct
microenvironments; (4) Dispersion –bacteria detachment from the biofilm. The timeline of biofilm
development is variable depending on the organism involved (Figure 1).

Figure 1 – S.aureus biofilm growth cycle(24)
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1 - Initial Attachment - During initial attachment, an individual planktonic cell will
reversibly associate with a surface, and if the cell does not dissociate, it will bind irreversibly to
the surface. Attachment is mediated through surface proteins, referred to as microbial surface
components recognizing adhesive matrix molecules (MSCRAMMs) (25). The fibronectin-binding
protein A and B (FnBPA, FnBPB), the collagen-binding protein Cna and the fibrinogen-binding
proteins, clumping factor A and B (ClfA and ClfB), belong to this family (26, 27). During
infection, these proteins play major roles in attachment to host factors such as fibrinogen,
fibronectin, and collagen. Biofilms in PJIs can form on all types of orthopedic components, as well
as accessory materials such as sutures and bone cements, regardless of the construction material
(28).

2- Accumulation and early biofilm formation - Once bacteria are attached, they produce
an extracellular polymeric substance (EPS), which can vary from species to species and even
between strains. On the surface begin to transition from the planktonic (free floating) to the biofilm
phenotype where they begin to produce EPS and undergo cell division to produce small aggregates
and clusters (23). Cells in the nascent biofilm can also undergo autolysis, releasing extracellular
DNA (eDNA) which has been shown to play a structural role in biofilm EPS. Furthermore, these
polymers can interact through polymer entanglement, electrostatic interactions, and cross-linking
to form complex polymer networks.
3- Maturation - As cells divide and EPS is formed, the biofilm structures become larger
and develop a three-dimensional architecture which leads to the development of
microenvironments, combined with structural stability. Ex vivo microscopic examination of
clinical specimens from orthopedic infections reveals that biofilms usually appear as aggregates
with hemispherical-like structure, which are heterogeneously distributed on surfaces (29). Tracer
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studies have shown that although there can be fluid flow in channels around the biofilm structure
within the EPS matrix itself, there is no advective flow and mass transfer is limited by diffusion.
As the biofilms become thicker, this diffusion limitation results in sharp gradients building up
within biofilms as nutrients (i.e., glucose and oxygen) are consumed by respiring bacteria on the
periphery of the aggregates faster than they can diffuse inward. Similarly, metabolites such as cell
signalling molecules used to coordinate behavior between individual cells in a population and
waste products, such as acids from fermentation, produced by cells in the interior of the biofilm
can build up. Thus, the periphery of the biofilm might be in a normal physiological range while
bacteria within a 100 μm may be in an anaerobic and acidic environment (29).
4. Dispersal – Dispersal is the last stage in the lifecycle of the biofilm. When biofilms get
starved, they can initiate dispersal through cell signaling pathways to use different mechanisms
such as the production of hydrolases that degrade EPS polysaccharides in the case of P. aeruginosa
or the production of surfactants (PSM) in the case of S. aureus (30, 31). Most of the time, biofilms
remain localized to an area and generally do not tend to spread; however, dispersal events may
explain periodic acute episodes of sepsis. Biofilm can either be found adherent to a surface or as
floating aggregates over a time period that ranges from minutes to hours in vitro, and days to weeks
or longer in vivo (32).
Biofilms can mature before they present diagnosable findings, because it is the host
response to bacteria outside of biofilms that leads to clinical symptoms, physical findings, and
positive diagnostic tests. This limits the opportunity to intervene before the biofilm is established.
In vitro experiments and in vivo animal studies report that progression of biofilms is mediated by
the interplay of a number of microbial, host, and environmental factors (21), and the timeline for
biofilm formation may not correlate with the onset of infection symptoms.
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1.3.2 Biofilm – Structure Matrix
The S. aureus biofilm matrix is a complex glue that encases all of the cells in the mature
structure, and it is thought to be composed of host factors, secreted and lysis-derived proteins,
polysaccharide, and eDNA. A major constituent of the biofilm matrix is polysaccharide
intercellular adhesin (PIA), also known as poly beta-1,6-N-acetyl-D-glucosamine (PNAG) (33).
The PIA polymer plays an important role in the structural integrity of biofilms in vitro and in vivo.
PIA is an important component in both S. aureus and S. epidermidis biofilms and is produced by
enzymes encoded in the icaADBC locus. It is composed of β-1,6-linked N-acetylglucosamine
polymer, and the proteins encoded in the ica locus are responsible for the synthesis, export, and
modification of PIA. Numerous studies have identified S. aureus strains capable of forming icaindependent biofilms made up of proteins and eDNA, which act as intercellular adhesins in the
absence of PIA (34-36). Due to the negative charge of the DNA polymer, eDNA potentially acts
as an electrostatic polymer that anchors cells to a surface, to host factors, and to each other. Early
biofilms are most sensitive to DNase treatment, suggesting that eDNA may be important during
attachment (37).

1.3.3 Quorum sensing (Role of glucose in vitro and agr)

Intercellular signaling, often referred to as quorum sensing, has been shown to be
involved in biofilm development by several bacteria (38). The S. aureus quorum-sensing system
is encoded by the accessory gene regulator (agr) locus and the communication molecule that it
produces and senses is called an autoinducing peptide (AIP) (39). Yarwood et al.(38) reported
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that the agr quorum-sensing system is involved in biofilm detachment. This study demonstrated
that bacteria dispersing from biofilms displayed high levels of agr activity, while cells in a
biofilm had predominantly repressed agr systems forming more robust biofilms compared to
wild types strains (40). Furthermore, Boles et al.(41) suggested a role for the agr system in S.
aureus biofilm development, as agr mutants exhibit a high propensity to form biofilms and that
repression of agr is necessary to form a biofilm and that reactivation of agr in established
biofilms through AIP addition or glucose depletion triggers detachment. Additionally, Regassa et
al. also reported that growth on rich media containing glucose represses the agr system through
the no maintained generation of low pH (42).

1.3.4 Surface Properties for Biofilm formation

The physicochemical properties of implants that are known to affect the time required and
robustness

of

the

established

biofilms

include

surface

chemistry,

surface

charge,

hydrophilicity/hydrophobicity, micro/nano-topography, and porosity (43, 44). In vitro experiments
and in vivo animal models have found that modification of implant surface can decrease bacterial
adherence, and thus decrease biofilm formation leading investigators to seek physico-chemical
surface modifications and coatings to inhibiting bacterial adhesion to theoretically decrease the
risk of infection without limiting osseointegration (45). However, biofilms can form on almost
all prosthetic and biological surfaces (21).
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1.4 S. aureus Biofilm-Related Diseases

S. aureus has been known to infect and form a chronic biofilm infection most often on
orthopedic implants including prosthetic joints, wires, pins, external fixators, plates, screws and
nails (46). Other medical devices that are prone to biofilm infection include stents, ventilators,
intravenous catheters, invasive blood pressure units, infusion pumps, cardiac defibrillators,
mechanical heart valves, aspirators, pace makers and cosmetic surgical implants. During cases of
implant infection, the infection can occur during implantation, subsequent trauma or
hematogenous seeding, as the surface of implant becomes coated with host derived extracellular
matrix proteins, providing a rich surface for bacterial attachment (46).

1.5 Diagnosis of a biofilm
Commonly used tests or techniques available to diagnose PJI including either the direct
method or the indirect method. The direct method involves laboratory isolation of the pathogen
responsible for the PJI through either aspirate or tissue samples. Biofilm bacteria can be difficult
to culture because of poor isolation and poor growth characteristics due to relatively dormant
persisters and small colony variants (47). Some of the possible solutions for improving the
isolation of these bacteria include the use of sonication of retrieved implants (48), as well as use
of methods such as polymerase chain reaction (PCR), which help in tackling poor growth
characteristics without depending on pathogen growth or culture.(49)
The indirect method includes some of the tests related to the host response to infection
without the isolation of the actual pathogens. These indirect tests include the following:
erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) (17), synovial cell count and
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neutrophil percentage (50), leukocyte esterase (51), alpha-defensin(52), d-dimer (53) and histology
(neutrophils per high-powered field). Unfortunately, there is no single accepted set of diagnostic
criteria as yet for PJI and in certain low-grade infections eg. Cutibacterium acnes, several of these
criteria may not be routinely met despite the presence of PJI (38).

1.6.1 Management strategies for S. aureus biofilm infections

There are many management strategies and protocols to treat PJI, which need to be
individualized to each patient to maximize success. This can be in the form of antibiotic
suppression; debridement with retention of prosthesis (DAIR);(10, 11) or excision arthroplasty
including single-stage revision (11), two-stage revision(12), multiple- stage revision, partial
revision, and even arthrodesis or amputation (13). Use of cement or calcium sulfate beads has
shown some efficacy in preventing infection via inclusion of an antimicrobial agent at the site of
infection, which provide a rapid release of high concentrations of antibiotics at the wound site
(54). Calcium sulfate beads also dissolve and so do not require surgical removal. The antibiotic
selected for inclusion in beads must be active against the causative microbes & available as a
powder that will harden properly and able to maintain activity despite the heat generated during
the polymerization process (55). The majority of the agent is released in a biphasic manner, in the
first few hours to days after implantation, with the remainder leaching out slowly over a matter of
weeks, months or in some cases, years (56). Elution rates depend on conditions such as eluent
solvent and pH. The elution characteristics of specific antibiotics vary depending on cement type,
although Palacos cement provides more complete elution of most agents, including the commonly
used aminoglycosides (57).
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The majority of present treatment strategies are maximally invasive therefore, impossible
in patients with high comorbidities. Furthermore, the increasing antibiotic resistance of bacteria
raises concern and limits the choices of antibiotics (58, 59). Therefore, it is vital that novel, noninvasive management options such as non-contact induction heating of metallic implants for the
prevention and treatment of biofilm infections in implants are developed to reduce the burden of
more invasive and extensive revision surgeries and possibly improve effectiveness of present
standard of care practices.

1.6.2 Antibiotic resistance and tolerance

Antibiotic resistance generally means an increase in the minimum inhibitory
concentration (MIC) value of an antibiotic due to a permanent change in the bacteria. Antibiotic
tolerance, on the otherhand, is the ability of cells to survive the effect of an antibiotic due to a
reversible phenotypic state (60). The use of these definitions is well suited for planktonic cells,
but for biofilms, it is used in a different context. In biofilms, antimicrobial tolerance is related to
the mode of growth of the biofilm. This is different from bacteria growing in planktonic culture,
which, usually, will show susceptibility to antimicrobials (61). Biofilm formation is the natural
state for the vast majority of bacteria in vivo. Therefore, antibiotic tolerance is a natural state of
biofilms. Also, antibiotic resistance is a natural phenomenon, since bacteria have evolved to
resist the action of natural antibacterial products for billions of years in the absence of human
activity (62).

Antibiotic tolerance has been reported for a diverse number of bacterial species for a wide
range of classes of antibiotics. Often the concentration required to achieve even a 3-log reduction
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is well above the therapeutic window of what can be achieved systemically (23). Main factors
promoting biofilm-specific antibiotic tolerance/ resistance include:

1 -Bacterial dormancy- limitation of nutrients inside biofilm, can lead the bacteria to go
into a slow growing or dormant phenotype and thus are not engaging in cellular processes (i.e.,
cell wall synthesis, protein synthesis, DNA replication) which are interrupted by conventional
antibiotics which are otherwise effective against rapidly growing cells.

2- Biofilm Thickness – In order to penetrate the cells within the biofilm, antibiotics have
to penetrate the EPS slime matrix. The time to diffuse into the biofilm is proportional to the square
of the distance traveled, which depends on the thickness of the biofilm. In addition to diffusion,
limitation cationic antibiotics such as tobramycin and vancomycin (two commonly used antibiotics
added to bone cement) have been shown to bind with anionic components (polysaccharides and
eDNA) in the EPS further hindering transport into P. aeruginosa and S. epidermidis biofilms. In
these studies, and other studies, subminimum inhibitory concentrations (sub-MIC) of antibiotics
have been shown to stimulate the production of biofilm or EPS components such as eDNA,
presumably as a defense mechanism (16, 63).
3- Persister cells – Bacterial cells may escape the effects of antibiotics without
undergoing genetic change; these cells are known as persisters. Unlike resistant cells that grow in
the presence of antibiotics, persister cells do not grow in the presence of antibiotics. These
persister cells are a small fraction of exponentially growing cells (due to carryover from the
inoculum) but become a significant fraction in the stationary phase and in biofilms (up to 1%).
Critically, persister cells may be a major cause of chronic infections (47). These persister cells
arise due to a state of dormancy, as a state in which cells are metabolically inactive. Persister
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cells enter a dormant state regardless of nutrient availability and appear to be responsible for the
resistant nature of chronic infections, since antibiotics kill the majority of cells. However,
persisters remain viable and repopulate biofilms when the level of antibiotics drops (47).
Quorum-sensing (Q-S) regulates several factors that contribute to biofilm formation and
persistence. Q-S is involved in the production of eDNA, which inhibits the penetration of some
antibiotics into the Biofilm. Since there is no indication that Q-S promotes antibiotic tolerance in
planktonic cells, this mechanism maybe biofilm-specific (61).
4- Sub-minimum inhibitory antibiotic concentration -Sub-minimum inhibitory
concentrations of a variety of antibiotics were found to induce biofilm formation in a number of
phylogenetically diverse Gram-positive and Gram-negative bacteria in vitro (64). It is likely that
some bacterial cells in biofilm are exposed to sub-MIC levels of antibiotics during antimicrobial
chemotherapy due to falling concentrations by dilution or diffusion gradients for antibiotics in
biofilm. Sub-MICs of antibiotics can induce mutagenesis, which confers resistance to other
antibiotics (65).

1.6.3 Present management options for biofilm related periprosthetic joint infections

There are many therapeutic strategies to treat PJI, which need to be tailored to each patient
to maximize success. It is essential to have a multidisciplinary approach between microbiologists,
surgeons, and infectious disease departments to yield the best outcome in these challenging
situations (16). There are many management strategies and protocols to treat PJI, which need to
be individualized to each patient to maximize success. This can be in the form of antibiotic
suppression; debridement with retention of prosthesis (DAIR) (10, 11), or excision arthroplasty
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including single-stage revision (11), or two-stage revision (12), multiple- stage revision, partial
revision (13) and even arthrodesis and, if necessary, amputation. The majority of present treatment
strategies are maximally invasive therefore, impossible in patients with high comorbidities along
with the increasing antibiotic resistance of bacteria, raises concern and limits the choices of
effective antibiotics (58, 59). Therefore, it is paramount that alternative modalities of biofilm
treatment and eradications of infections in orthopaedic implants are developed.

1.7. – Need for novel alternatives treatment options for biofilm management

This subject was assigned to the Biofilm Workgroup during the second International
Consensus Meeting on Musculoskeletal Infection held in Philadelphia, USA (ICM 2018) with
representations of experts from around the world. The aim of the meeting was to identify the best
practices & develop research studies, dedicated to advancing our understanding of biofilms and
their role in human implant-related infections. The consensus document suggested biomedical
research funding agencies and the pharmaceutical industry should recognize these areas as a
priority, for urgent development of better diagnosis and eradication strategies (21).

1.7.1- Effects of heat on biofilm

In food preservation studies, heating has been reported to be an effective way to reduce the
bacterial load of S. aureus (66). The effect of heat treatment on three physical properties of the
biofilms: the bacterial cell morphology and viability, the polymeric properties of the extracellular
polymeric substance (EPS) and the rheological (study of the deformation and flow of matter)
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properties of the bulk biofilm have been studied & observed to have an order of magnitude
reduction in the biofilm yield stress after 60 °C temperature treatment. No such difference was
found for treatment at 45 °C. From these results, it has been established that the yield stress of
bacterial biofilms is temperature-sensitive, and that this sensitivity is correlated with cell viability.
The yield stress is of particular interest, as it is a measure of how much force must be applied to
an apparently solid material to get it to flow and show liquid-like behavior (67).
The observed significant decrease in yield stress with temperature suggests a means to
weaken the mechanical integrity of S. epidermidis biofilms with applications in areas such as the
treatment of biofilm-infected medical devices (67).

1.7.2 Non-contact electromagnetic induction heating for eradicating biofilm

Heating is an effective way to reduce the bacterial load in food preparation, and studies on
hyperthermia treatment for cancer have shown that it is possible to heat metal objects with pulsed
electromagnetic fields selectively (PEMF). Non-contact induction heating of a titanium disk is
effective in reducing bacterial load in vitro (68). Log reduction of bacterial load were calculated
using the following equation: log10(A/B), where A is the number of viable micro-organisms
before the experiment in CFU/ml and B is the number of viable micro-organisms after the
experiment in CFU/ml. These promising results can be further explored as a new treatment
modality for infections of metal orthopedic implants (68).

1.7.3 PEMF
Non-contact induction heating (NCIH) uses the principles of pulsed electromagnetic fields
(PEMF) to induce ‘eddy currents’ within metal objects which causes them to heat up. This heat
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can be used to cause thermal damage to bacterial biofilms on the metal implant, hence, killing the
bacteria and weakening the biofilm (68, 69). In the field of hyperthermia cancer treatment, several
studies have shown the feasibility of induction heating of "thermal seeds" and nanoparticles (70).
In the field of fracture healing with shape memory devices. Müller et al. (71) have also shown the
feasibility and safety of contact-free electromagnetic induction heating of Nickel Titanium
alloy (NiTi) implants in a rat model.
Hence this novel application of heat can be used as an adjuvant to chronic suppressive
antibiotic therapy or severely immunocompromised patients, who are not fit for surgery. The
metal implant fixed to the bone can be heated noninvasively with care taken to avoid excessive
heating to areas that are in close contact with important anatomical structures. Alternatively,
NCIH can be used during surgery to increase the effectiveness of the surgical procedure such as
in Debridement, Antibiotics and Implant Retention (DAIR), allowing heating of parts of the
implant that cannot be reached and mechanically cleaned. During surgery, soft tissue can be
protected by keeping it away from the heated part of the implant.

1.7.4 Antibiotic synergy
Since contemporary treatment methods such as surgical debridement with pulse lavage and
antibiotics may not be effective once biofilm formation has reached a certain bioburden threshold,
induction heating may prove to be a valuable addition to these treatments (72). Furthermore, the
increasing resistance of bacteria to antibiotics raises concern and limits the choice of antibiotics
(73). Hajdu et al.(74) have shown that the antibacterial activity of antimicrobial agents is
significantly enhanced by increasing the ambient temperature. Pijls et al.(75) report that in
induction heating, the heat originates at the biofilm-implant interface and travels into the biofilm,
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whereas the cocktail of antibiotics diffuses into the biofilm starting at the outer border of the
biofilm and ultimately ending at the biofilm–implant interface. This bi directional attack may be a
mechanism for the observed synergistic effect that leads to total eradication (75). Thus, the PEMF
may work synergistically with thermal damage and antibiotics. These synergistic effects require
further investigations, since the future application of non-contact induction heating of metal
implants, will likely be applied in a clinical setting where antibiotics are part of the treatment
strategy (68).

1.7.5 Concerns - Temperature elevation & effect on soft tissues

There may be concerns for potential tissue necrosis with induction heating due to relatively
high temperatures at the prosthesis-bone interface. Temperatures greater than 50°C (122°F) occur
routinely during the process of intramedullary reaming as well as stimulation of revascularization
by the breaking-up of intramedullary scar tissue (76, 77).There are also animal experiments that
confirm the lack of necrosis after induction heating up to 60°C (71). Samara et al. (78) have shown
that bone cement, reaches temperatures of 80°C for more than 10 min during the curing process.
Additionally, special heating techniques such as segmental induction heating can be used to apply
localized heating to a segment of an implant, using the remainder of the implant as a heat sink
(79). The surrounding tissue is heated to some extent by thermal conduction from the heated metal,
but if the tissue is well perfused by arterial and venous blood flow, the heat will very likely be
significantly reduced as in coagulation procedures (80, 81). Since cemented prostheses have an
excellent long-term track record in several national joint registries, the concern of necrosis due to
temperatures of around 60°C from curing cement remain theoretical. Studies with bone cement
and drilling in bone have shown that curing temperatures of bone cement and drilling in cortical
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bone readily exceed 60°C, hence induction heating at this 60°C temperature range should be safe
which was found to be the most effective temperature in the present study (82, 83).
1.8 Project Rationale

Periprosthetic joint infection (PJI) is a devastating complication of surgery, often
requiring multiple rounds of antibiotic therapy and surgeries to treat. Furthermore, the increasing
resistance of bacteria to antibiotics raises concern and limits the choice of antibiotics (73).
Contemporary treatment methods such as surgical debridement with pulse lavage and antibiotics
may not be effective once biofilm formation has reached a certain bioburden threshold. This
multidisciplinary study between orthopaedics, microbiology and medical biophysics, will serve
as a foundation to better understand biofilm related implant infections and develop novel
strategies for its clinical management.

Staphylococcus aureus is a major cause of prosthetic joint infection (PJI) in which it forms
adherent biofilms. Biofilm associated infections are difficult to treat as they have increased
resistance to various antimicrobial agents, which means infected implants often require multiple
procedures and prolonged antibiotic therapy. Bacterial biofilm infections can be difficult to
eradicate with antimicrobials (84). Furthermore, increasing antibiotic resistance of bacteria raises
concern and limits choices of antibiotics (84). However, knowledge gaps exist in the potential role
of physical methods such as heat, for biofilm treatment. Therefore, it is vital that novel treatment
options such as NCIH are explored that improve outcome, reduce patient morbidity and mortality
and can be effectively used in the treatment of biofilm infections in implants.
Studies dedicated to advancing our understanding of biofilms and implant-related
infections are required for development of better diagnosis and eradication strategies. A new and
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emerging method of treatment of PJI is non-contact induction heating (NCIH) of metal implants.
Hence we sought to investigate the feasibility and effectiveness of NCIH of metal implants in
reducing bacterial load within surface associated biofilms in vitro (68). It is currently unknown
whether NCIH can reduce or even eradicate S. aureus from the biofilm on stainless steel and
titanium alloys, which are common metals used in orthopedic trauma and arthroplasty implants. It
is important to evaluate the possible synergistic effect of NCIH and antibiotics, because NCIH will
very likely be applied to a scenario in a clinical setting where antibiotics are part of the established
treatment protocol and heat has been shown to enhance the antibacterial activity of antimicrobial
agents against staphylococcal biofilm (74).
This multidisciplinary collaboration study will help provide a better understanding of the
environment of the biofilm and could lead to development of novel treatment strategies, which in
the future can be applied for further validation via animal testing.

1.9 Research objectives
The purpose of this study was (1) to study the potential role of NCIH as a method for
reducing bacterial load in a biofilm in-vitro model and (2) to investigate its synergistical use with
antibiotics, to increase the effectiveness of antimicrobial therapy.

Chapter 2 - Material and methods

In order to advance our understanding of the role of biofilms in PJI, it is vital that novel
treatment options such as NCIH and its possible synergistic effects with antibiotics are explored
that can potentially improve treatment outcomes and reduce patient morbidity and mortality.
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2.1 Purpose

The purpose of the current study was (1) to design an in vitro model to test the effect of
heating duration and temperature of non-contact induction heating stainless steel and titanium
washers inoculated with S. aureus based mature biofilm to study the potential role of physical
methods (heat) as a non-invasive method for the eradication of biofilm. (2) To determine the
possible synergistic effects of non-contact heating with antibiotics (vancomycin).

2.2 In Vitro Biofilm Growth

2.2.1 Bacteria Strain and culture conditions

S. aureus strain USA300 was used throughout this study due to its association with
implant-based infections. CA-MRSA strains such as USA300 have the ability to spread readily
(6). It has been involved in epidemiologically unassociated outbreaks of skin and soft tissue
infections in healthy individuals in at least 21 US states, Canada and Europe (85). These microorganisms were chosen as representatives of gram-positive bacteria, associated with infections
of orthopedic implants, as S. aureus is a major cause of hospital acquired & implant associated
infections (86).
The bacteria were grown overnight in 5mL cultures of tryptic soy broth (TSB) and 600µL
was pelleted by centrifuging and then normalized to an OD600 of 1.0 in 1mL of sterile saline.
Stainless steel and titanium washers (DePuy Synthes 13mm Spherical Washers, dimensions -
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13mm x 1.5 mm x6.6mm, used with 4.5 - 7.3 mm diameter screws and manufactured from stainless
steel and titanium), were sterilized by autoclaving and placed into the wells of a 12 well tissue
culture plate (Figure 2). The wells containing washers were then filled with TSB and inoculated
with S. aureus at an OD600 of 0.01 and 0.4% glucose was added to the growth media (TSB-G) to
stimulate biofilm formation as per earlier work done by Boles et al.(41). The plates were then
incubated statically at 37ºC for 24 hours to allow the biofilms to grow.

2.3.2 Non-Contact Heating
The stainless steel and titanium washers were exposed to a PEMF from an induction cooker
(Master Chef Induction Hot Plate ,1800W) after contamination. An induction cooker was chosen
because several studies have indicated that the PEMF generated by induction cookers, on the order
of 20 kHz to 30 kHz, is safe for humans for non-contact temperature measurement (87). The
cooktop had been modified in order to automatically activate and deactivate to maintain the heating
of the washers at a specified target temperature. Multiple trials were done to check the maximum
temperature attained by the washers when heated to the maximum capacity of the induction heater.
Due to physical limitations such as the size and shape of the washers/ induction heater, the
maximum temperature that could be reliably maintained was 60ºC. This temperature was chosen
because it has been shown to have a 6-log reduction when used alone , as well shown complete
eradication of biofilm when used with a cocktail of antibiotics (68, 75). This temperature has been
reported to be within the clinically safe range as several studies with bone cement and drilling in
bone have shown that curing temperatures of bone cement and drilling in cortical bone readily
exceed 60°C (82)
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After biofilms had grown on the washers, they were gently rinsed with 300µL sterile saline
before being exposed to a pulsed electromagnetic field (PEMF) with a maximum of 1800 watts at
27 kHz to evaluate the relationship between alternating magnetic field (AMF) exposure and
bacterial survival. An identical control washer that did not have a surface associated biofilm, was
used for each the stainless steel and titanium washers as a control to monitor the temperature during
heating. All discs were heated up to and then maintained at 60ºC for the specific times indicated
for each experiment.

Figure 2 - Sterilized washers placed into the wells of a 12 well tissue culture plate.

2.3.3. Bacterial Enumeration

Washers containing biofilms that had either been heated using the PEMF, or non-heated
control samples were placed into 13mL snap cap tubes with 3mL of sterile saline. These samples
were then sonicated using a probe sonicator (Misonix XL2020) to disrupt the biofilms but did not
affect bacterial viability (Figure 3).
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Sonication is the application of ultrasonic energy to a sample immersed in a fluid (the
sonicate fluid) to dislodge biofilm embedded bacteria. Through this process, the sensitivity of
cultured samples is improved. The efficiency of sonication to achieve dislodgment of bacteria
from biofilm on titanium or stainless steel implants has been shown to be superior to scraping with
a surgical blade (88).
These samples were then serially diluted and 10µL drops were plated in duplicate on
tryptic soy agar (TSA) plates, which were incubated at 37ºC overnight to determine the number of
colony-forming units (CFU) for each of the samples.
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Figure 3- Sonication and plating on TSA plates
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2.3.4 Temperature Measurement

Washers were placed the wells of a sterile plastic dish that was designed such that each
well would receive identical levels of heat from the induction cooktop. A control washer of the
same material as those being heated was placed into one of the wells and a calibrated thermometer
(thermocouple) was used in order to constantly measure the temperature of the control washer.
The control temperature readings were used as feedback to deactivate heating when the washers
reached the target temperature and then reactive heating as soon as the washer dropped below the
target temperature in order to keep the temperature constant. Figure 4 shows the arrangement of
the induction system and images of a heated washers. Our study was limited by the physical
characteristics of the heater and washers and as such, the maximum temperature that could be
reliably reached and maintained for the implants was 60°C. Notably, this temperature has
previously been shown to have inhibitory effects in a planktonic heating mode. Pijls et al. (70)
grew a S. aureus biofilm model on titanium alloy cylinders and exposed to incremental target
temperatures (35°C, 45°C, 50°C, 55°C, 60°C, 65°C, 70°C) for up to 3.5 minutes with NCIH and
reported that at 60°C and higher there was a 6-log reduction (70).
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Fig. 4 Photograph of the arrangement of the induction systems, washers on a modified platform; with
temperature data logging with laptop; IH- Inductiotion heater ; TC – Thermocouple Temperature sensor ; DL
– Data logger ( Laptop) , CP- Custom petridish

2.3.5 Effect of Temperature and Duration
The washers were initially exposed to maximum target temperature of 60°C for 3.5, 10 and
15 minutes. The initial duration of 3.5 minutes was chosen from results in published studies with
food products which revealed that 3.5 minutes caused at least a 3-log reduction of bacteria (66).
Pijls et al. (68) showed an effect of a more than 6-log reduction for 2.5, 3.0 and 3.5 minutes at
60°C, additionally total eradication of the biofilm has been reported with induction heating at 60°C
at 3.5 min with subsequently exposure to cocktails of vancomycin, rifampicin and NAC (75).
Furthermore, to test the effect of longer heat treatments, washers were maintained at 60ºC for 10
and 15 minutes before plating to enumerate any viable bacteria that remained. Washers that were
heated for the various times were compared to control washers that were not exposed to the PEMF.

2.3.6 Effect of Vancomycin
In a clinical setting, intravenous vancomycin is the drug of choice for most MRSA
infections seen in hospitalized patients. It can be used both as empiric and definitive therapy as
most MRSA infections are susceptible to vancomycin. The dosage depends upon the type and
severity of the infection. Vancomycin trough is obtained just before the fourth dose to ascertain a
therapeutic level. The goal trough range typically is between 10 and 20 ug/mL. For complicated
infections, the goal is between 15 and 20 ug/mL. Vancomycin and daptomycin are considered
adequate empiric therapy according to the Infectious Diseases Society of America guidelines of
2011. MRSA isolates in the bloodstream with vancomycin MIC greater than or equal to 2 ug /mL
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may not respond adequately to vancomycin. Therefore, in these cases, daptomycin is a better
option (5).
Hence in order to determine if heating the biofilm resulted in increased sensitivity to
vancomycin, we conducted the following series of experiments.( Table 1 ) Washers that had been
heated for 10 minutes as previously described were then placed back into new 12 well plates
containing sterile TSB with vancomycin added at 2 or 20ug/mL. These concentrations were chosen
as they are sufficient to kill planktonic S. aureus, in vitro and fall within the normal concentration
range of intravenous vancomycin therapy for infected patients in vivo (5).
After a 24-hour incubation with vancomycin, the washers were sonicated and plated for
CFUs as described above. These washers were compared to both control washers that were heated
and then put into fresh media with no vancomycin, and control washers that were not heated but
were exposed to the same concentration of vancomycin to determine if there was any synergistic
effect of heat and vancomycin compared to either treatment alone.

Time Duration

Vancomycin (Conct.)

3.5

10

15

(Low)2ug/mL

(High)20ug/mL

S.S washers

+

+

+

+

*(Pending)

Titanium

+

+

+

*(Pending)

+

Table 1 – Flow chart of various conditions tested (Temperature, Duration, Antibiotic concentration)
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2.3.7 In Vitro Growth Analysis
Data was graphed and analyzed using GraphPad Prism V7.0 (GraphPad Software, La Jolla,
CA). Data points are presented as the mean +/- standard deviation for at least 3 biological replicates
from a minimum of 2 independent experiments. Statistical significance determined by a one-way
ANOVA with Dunnetts multiple comparison * P<0.05, ** P<0.01, *** P<0.001.

Chapter 3- Results

3.1 Biofilm grown on washers
To initially explore the effects of heat and antibiotics for the treatment of biofilm-based
implant infections, the first requirement was establishing the ability to grow biofilms on metal
implants. To do this, we used an S. aureus, in vitro biofilm model using strain USA300 grown in
the presence of stainless-steel & titanium washers ( N= 3 in each group over 2 independent
experiments). Bacteria were grown on the washers within sterile culture plates using TSB (tryptic
soy broth) growth media with or without the addition of 0.4 % glucose. This method has previously
been demonstrated by Lim et al., to stimulate biofilm formation (89). After growth the washers
were rinsed with sterile saline to remove any non-adhered bacteria before sonicating and plating.
It was found that the control specimens that did not get glucose had approximately 12-fold fewer
bacteria adhered to the surface of the washers than those grown in the presence of glucose. This
confirmed that the addition of 0.4% glucose to TSB is an effective method for establishing adherent
biofilms on metal washers (Figure 5).
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Figure 5 – The ability of S. aureus to form an adherent biofilm on stainless-steel washers. S. aureus USA300
grown in the presence of washers with or without glucose supplementation. Samples were incubated statically
for 24 hours before being washed then sonicated and plated to determine the number of adherent CFUs. Data
shown as the mean +/- SD and statistical significance was determined by an unpaired T-test where * P<0.05.
N=3

3.2 Tested effects of Vancomycin treatment on pre-formed biofilm
The next objective was to confirm that biofilm formation leads to increased antibiotic
resistance. To this end, vancomycin, which is typically used clinically to treat MRSA infections,
was added to the culture media after the biofilms had been grown on the washers. Vancomycin
was added at 2µg/mL, double the concentration previously shown to inhibit the growth of
planktonic S. aureus USA300, and incubated for another 24 hours before plating, as done before.
(N=4 for no Vancomycin and N=6 for addition of Vancomycin over 2 independent experiments)
Twenty-four hours incubation was chosen as it is the accepted standard for S. aureus growth
experiments and MIC testing is done at 24 hour time intervals (90). Addition of vancomycin lead
to a higher CFU/mL, which could possibly be due to some contamination, dilution error or use of
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sub-MIC vancomycin use. This confirmed that the biofilms grown on the washers are resistant to
vancomycin at a concentration known to be effective against planktonic bacteria. This resistance
to antibiotics necessitates the study of novel methods for treating biofilm-based implant infections
(Figure 6).

Figure 6 – S. aureus biofilms are resistant to vancomycin treatment. S. aureus USA300 biofilms were grown on
stainless-steel washers as before, after growth the washers were placed in fresh media either with or without
2µg/mL vancomycin and incubated for 24 hours before plating. Data are presented as the mean +/- SD with and
N=4 for -Vanc and N=6 for +Vanc over 2 independent experiments.

3.3 Tested effects of duration of heating ‘Thermal shock’ via induction heating on biofilm
After establishing an in vitro model of a biofilm with resistance to regular antibiotic
(vancomycin ) use , I sought to study NCIH as a novel method for treating biofilm-based implant
infections, as recently reported by Pijls et al (68). To analyze the effects of duration of heat
exposure on a mature biofilm on an orthopedic implant, each group of washers (stainless steel and
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titanium), with surface-associated biofilms, were heated to and maintained at 60C for different
time intervals i.e 3.5, 10, 15 minutes ( Stainless steel – N= 3 each , Titanium 5 each). These heated
washers were then compared to washers that were not exposed to heat to determine the difference
in bacterial burden. After heating, the stainless-steel washers showed a 24-, 25-, and 48-fold
reduction (3.5, 10, and 15 minutes respectively) on average in CFU/mL compared to controls.
However, the titanium washers showed a 5-, 20-, and 24-fold reduction on average compared to
controls for the same conditions. I did an ANOVA and multiple comparison for the stainless-steel
washers to compare the 3.5 minutes to 10 minutes and the 10 minutes to the 15 minutes. For the
3.5 vs 10minutes P=0.997, and for the 10 minute vs 15 minutes P=0.884, which are both nonsignificant. For the titanium washers the 3.5 vs 10 minutes P=0.128, the 10 vs 25 minutes P=0.997
and the 3.5 vs 15 minutes P=0.114. It is worth noting that although the titanium washers had
smaller decreases in CFU/mL compared to the stainless-steel washers for the same conditions, the
results were more statistically significant, which is likely due the larger number of replicates for
the titanium washers. While the bacteria were not eliminated this has shown that biofilm grown on
stainless steel & titanium washers heated to 60C showed significant reduction in the number of
bacteria adhered to the surface. Because the differences observed when heating for 10 or 15
minutes were comparable, the 25 fold vs 48 fold difference is not statistically significant because
there are only 3 replicates and there is some variation between each of the replicates, 10 minutes
was chosen as the standard heat treatment for further testing. (Figure 7).
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Figure 7 – Induction heating of mature biofilms grown on stainless steel and titanium washers. USA300 based
biofilm grown on stainless steel (A) or titanium (B) washers, either exposed to thermal shock of 60C for various
times or left unheated. Data shown as the mean +/- SD, statistical significance determined by a one-way ANOVA
with Dunnetts multiple comparison * P<0.05, ** P<0.01, *** P<0.001. In Stainless steel (A) N=5 for the control
no heat, N=3 each for 3.5/10/15-minute intervals for both groups over 2 independent experiments, in (B)
Titanium N=4 for the control and N=5 for all other samples over 2 independent experiments.
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3.4 Tested Synergistic effects of low dose Vancomycin after thermal Shock (Stainless steel
washers)
The next objective was to determine whether there is a synergistic effect of vancomycin
treatment after an initial thermal shock to the biofilm. As a control (N=5) to establish the starting
number of CFUs in the biofilms, plating was done for a group of washers before heating, then the
remaining washers with biofilms were heated at 60ºC for 10 minutes, as mentioned before. Again,
stain less steel washers (N=5) were selected and plated to determine level of killing by thermal
shock alone, while the remaining washers that were heated, were then put into fresh media with or
without vancomycin (2µg/mL) and incubated for 24 hours before plating ( N=5 washers for “no
heat” and “heated” groups, N=3washers for “Heat+Vancomycin” and “Heat-Vancomycin, for all
other samples over 2 independent experiments).This concentration was chosen to represent
clinically relevant concentrations (91). It was found that the vancomycin (low dose) treatment after
thermal shock still had no effect and the number of CFUs in the biofilm actually increased,
matching the sample that had no vancomycin exposure. Therefore, while the heat causes
significant levels of bacterial death it did not restore planktonic levels of antibiotic sensitivity and
biofilm remained resistant to vancomycin (Figure 8).
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Figure 8 –Vancomycin (2µg/mL) is not effective against biofilms on stainless steel washers even after heating USA300 biofilms grown on stainless steel washers exposed either to thermal shock (60oC, 10minutes) alone, or
in combination with a secondary 24-hour incubation with or without vancomycin (2µg/mL). Data shown as the
mean +/- SD for N=5 for “no heat” and “heated”, N=3 for “Heat+Vanc” and “Heat-Vanc” Statistical
significance determined by a one-way ANOVA with a Dunnetts multiple comparison post-test where * P<0.05.
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3.5 Tested Synergistic effects of higher dose Vancomycin at (20µg/mL) after thermal shock
(titanium washers)
Since induction heat with low dose of vancomycin concentration did not show significant
decrease in CFU/ml , a similar set of experiments were repeated on titanium washers with a higher
concentration(20µg/mL ) of vancomycin (higher range of serum concentrations in IV therapy)
making it a clinically relevant concentration. As before, washers were selected (N= 3 titanium
washers in each group) before and after heating (60ºC, 10 minutes) to be plated as controls, and
the remaining samples that were heated were incubated in media with or without vancomycin
(20µg/mL) before plating.. There was a 20-fold decrease in CFU/ml after initial effect of thermal
shock, but then another 50-fold decrease for the washers receiving both the heat and then the high
dose vancomycin treatment for 24-hours. This dual treatment resulted in a ~1000-fold total
decrease in CFUs compared to untreated controls. This suggests that although the bacteria were
not eliminated there is a potential synergistic effect between the heat and antibiotic treatment
against biofilms (Figure 9).
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Figure 9-Vancomycin (20µg/mL) is effective against biofilms on titanium washers after heating. USA300 based
biofilm grown on titanium washers plated before & after exposure to thermal shock of 60C for 10 minutes.
After heating select washers were incubated with or without 20µg/mL vancomycin before plating. Data shown
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as mean +/- SD for N=3, statistical significance determined by a one-way ANOVA with a Dunnetts multiple
comparison where * P<0.05, ** P<0.01, *** P<0.001.

3.6 – Series of experiments pending due to interruptions caused by COVID-19
We had planned on the following experiments to better elucidate the relationship between
heating and antibiotics on both stainless steel and titanium washers, but the lab was closed because
of COVID-19. List of pending / possible future series of experiments include 1. Testing of Synergistic effect on
•

Heat + (high concentration) Vancomycin on Stainless Steel washers

•

Heat + (low concentration) Vancomycin on Titanium washers

2. Independent effect of (high cont.) Vancomycin on biofilm grown on Stainless steel
+ Titanium washers, (non-heated – control group)
3.

Synergistic use of antibiotic cocktail (eg. Vancomycin, Rifampicin / NAC)

4.

Replicate series of experiments in different species (eg. S. epidermidis)

Chapter 4 -Discussion and future directions

The effects of antibiotics and antimicrobial agents on bacterial biofilm infections have
received significant attention in the literature (86, 92). As strategies based on antibiotics typically
have shown to fail in the treatment of infected implants, the physical and mechanical properties of
biofilms, need to be researched as potential therapeutic targets. The physical methods that have
received attention are magnetic fields, ultrasound, and pulsed electrical fields (67, 93, 94).
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To establish the scope of potential role of physical methods, such as heat, we have
investigated the impact of heat treatment and its synergistic effects with antibiotic therapy on
stainless steel and titanium orthopedic implants (washers). Stainless steel and commercially pure
titanium are widely used materials in orthopedic implants. Stainless steel is the most frequently
used material in orthopedics because of its mechanical strength, low costs, and the possibility of
bending and shaping the implant to create a custom fit in the operating room. However, major
disadvantages of stainless steel are well-documented: surface corrosion phenomena and the high
rate of locally and systemically released corrosion products (95), which led many authors to
recommend the use of titanium for orthopedic implantation as an ‘bio-inert’ material (96). But
neither of the materials has been termed the ‘golden standard’ material in general (97).
The results of our study show that non-contact induction heating of orthopedic implants
appears feasible and was effective in vitro, in the reducing the bacterial load for S. aureus biofilm.
There was a 20-fold decrease in CFU/ml after initial effect of thermal shock, and then another 50fold decrease for the washers receiving both the heat and then the high dose vancomycin treatment
for 24 hours. But complete eradication was not observed.
Periprosthetic joint infection (PJI) is the leading cause of revision surgery, and is the most
challenging complication after total joint replacement (98). It is essential to have a multidisciplinary approach between microbiologists, surgeons, and infectious disease departments to
yield the best outcome in these challenging situations (16). There are many management strategies
and protocols to treat PJI, which need to be individualized to each patient to maximize success.
This can be in the form of antibiotic suppression; debridement with retention of prosthesis (DAIR)
(10, 11), or excision arthroplasty including single-stage revision (11), two-stage revision;(12)
multiple- stage revision, partial revision, and even arthrodesis or amputation.(13)
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The majority of present treatment strategies are maximally invasive; therefore, challenging
in patients with high comorbidities. The current gold stand of 2 stage revision surgery still cannot
treat 15-20% infections at 5 years (99). Hirakawa et al. (100) reported that reimplantation was
successful in 80.0% of knees with low-virulence organisms (coagulase-negative Staphylococcus,
Streptococcus), 71.4% with polymicrobial organisms, and 66.7% with high-virulence organisms
(methicillin-resistant Staphylococcus aureus) (100). Furthermore, the increasing antibiotic
resistance of bacteria raises concern and limits the choices of antibiotics(58, 59). Therefore, it is
vital that novel, non-invasive management options such as non-contact induction heating of
metallic implants for the prevention and treatment of biofilm infections in implants are developed
to reduce the burden of more invasive and extensive revision surgeries and possibly improve
effectiveness of present standard of care practices.
In our study, non-contact induction heating for 10 minutes at 60°C, on contaminated
stainless steel & titanium washers showed an average of 25- and 20-fold reduction in CFU/ml of
bacteria yield, respectively. Notably titanium washers had smaller decreases in CFU/mL compared
to the stainless-steel washers for the same conditions, the results were more statistically significant,
which is likely due the larger number of replicates for the titanium washers. Titanium may
demonstrate some bacteriostatic properties with a varying degree to different types of microorganisms (101). These results were comparable with a similar in-vitro study done by Pijls et al
which reported a 6-log reduction of bacterial load on titanium discs by using PEMF induction
heating at 60°C for 3.5 minutes (68).
In our study, the synergistical use of the dual treatment strategy (heat and antibiotics)
resulted in a ~1000-fold total decrease in CFUs/ml. Suggests the potential synergistic effect
between the heat and antibiotic treatment against biofilms. Although the bacteria were not
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completely eliminated , Hajdu et al (74). have also reported on the significant increased
antibacterial activity of antimicrobials agents by increasing the ambient temperatures of heating
and using high concentration of antibiotics. They reported that the moderate increase in the
incubation temperature to 45°C resulted in a decrease in biofilm thickness with treatment with
different antibiotics (daptomycin, tigecycline, fosfomycin, cefamandole and vancomycin) and
showed significant reductions in bacterial growth with high antimicrobial concentrations. As
compared to Hajdu et al.(74) , we did not incubate with antibiotics at higher temperatures, since
we heated the washers and then put them in antibiotics at 37°C. Pickering et al.(102) reported
that PEMF may work synergistically with thermal shock and increased the effectiveness of
gentamicin against the five-day biofilms of S. epidermidis, hence it may be of value in the
treatment of biofilm-associated implant-related infections. Since our planned set of experiments
were delayed due to restriction of COVID-19, we could not test for different cocktails of antibiotics
or different strains of Staphylococcus.
In our series of experiments, to observe the effects of Sub MIC dose of vancomycin on preformed biofilm, addition of vancomycin at 2µg/mL lead to a higher CFU/mL. This could possibly
be due to some contamination or dilution error. This ‘close to the mic’ concentration may have an
effect on the bacteria, which in response to this lower concentration of vancomycin, could change
their surface structure and actually cause more biofilm to form. Another possible reason that could
have led to higher CFU/ml rather than contamination could be that sub-MIC vancomycin can
induce biofilm formation. Sub MIC vancomycin has been reported to cause biofilm formation
(103). Sub-MIC (2ug/mL) which is 2x Planktonic MIC but is below the MIC for biofilms, was
added to pregrown biofilms, so it was sub-biofilm-MIC vancomycin and may have made more
adherence than the samples with no vancomycin. This was to be empirically tested but due to
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interruptions caused due to COVID-19, further testing could not be done. We would need more
experiments to prove that theory.
In our experiment, we were unable to show complete eradication of bacteria. Pijls et al.
(75), reported a total eradication of biofilm on titanium implants at 60 C, with a combination
induction heating, cocktail of antibiotics (vancomycin , rifampicin) and NAC. The possible
mechanism of this synergistical effect has been reported by them is that PEMF together with eddy
currents may interfere with the transport of charged molecules within the bacteria, at the implant
surface possibly making them more susceptible to thermal shock. Furthermore, with induction
heating the heat originated on the biofilm-implant interface, travels into the biofilm, whereas the
antibiotics diffuses into the biofilm starting at the outer border of the biofilm and ultimately ending
at the biofilm implant interface. This attack from two directions may be a mechanism for the
observed synergistic effect.
The major advantage of induction heating of metallic implants is that only the metallic
implant is actively heated while induction heating has no direct heating effect on the surrounding
tissue. The surrounding tissue is heated to some extent by thermal conduction from the heated
metal, but if the tissue is well perfused by arterial and venous blood flow, the heat will very likely
be significantly reduced as in coagulation procedures (81). Multiple concerns for potential tissue
necrosis with induction heating due to relatively high temperatures at the prosthesis -bone interface
may arise. However, animal model studies by Muller et al.(71) demonstrated evidence of a lack of
thermal necrosis by heating a nickel-titanium shape intramedullary rod in the femur of rats at 40°C
to 60°C using induction heating and demonstrated no necrosis of the surrounding bone and tissue.
Furthermore ,clinically relevant studies using drilling in bone and bone cement, which achieves
durable fixation for hip and knee implants, have shown that curing temperatures of cement and
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drilling in cortical bone readily exceed 60°C (78, 82, 83). Additionally, Pijls et al.(79) reported
heating techniques such as segmental induction heating, which can be used to apply localized
heating to a segment of an implant, using the remainder of the implant as a heat sink. Hence the
chosen temperature of 60°C is within the safe temperature range.
Various limitations exist regarding non-contact temperature control. The temperature
sensor such as the one used in our experiments cannot be readily used in clinical situations because
of the absence of direct contact, there is tissue and bone between the implant and the sensor. Cheng
et al. (104) developed a non-invasive temperature safety system, using remote acoustic sensing,
to detect sounds associated with boiling on the implant-tissue interface. Multiple studies regarding
hip Implants with temperature measurement sensors have been reported (105). Future research to
address these challenges might involve developing clinically relevant and safe implants with
temperature sensors.
Furthermore, our experiments were in vitro and may not translate entirely to in vivo
situations with possibility of more mature biofilms. Hyperthermia can have varying physiological
and molecular effects. Localized hyperthermia has been shown to increase blood flow and vessel
permeability, which could result in better availability of antibiotics, which could be helpful in
relieving the infection (106).
The future clinical application of non-contact induction heating can be used in an operative
or non-operative situation as part of a multi-modality treatment plan. The non-operative
application of NCIH can be used in clinical situations as an adjuvant to chronic suppressive
antibiotic therapy or severely immunocompromised patients, who are not fit for surgery. The metal
implant fixed to the bone can be heated noninvasively with care taken to avoid excessive heating
to areas that are in close contact with important anatomical structures. Since the current gold
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standard therapy, i.e. revision 2 stage surgery cannot completely treat 15-20% infections (99), the
noninvasive application of induction heating may be particularly beneficial in patients for whom
surgical treatment is not possible and receive suppression antibiotic therapy.
Alternatively, NCIH can be used during surgery to increase the effectiveness of the
surgical procedure such as in debridement, antibiotics and implant retention (DAIR).
Allowing heating of parts of the implant that cannot be reached and mechanically cleaned.
During surgery, soft tissue can be protected by keeping it away from the heated part of the
implant. Additionally, surgery allows for direct temperature control by direct temperature
measurement (e.g., thermocouple) or by IR thermal imaging.
Future work needs to be done to find the ideal conditions of heat antibiotic use and
applications as well as potential for implant related modifications. Further directions for implants
related modifications include, development of anti-biofilm agents, used as a coating to implants
to counteract bacterial adhesion. Surface treatment by natural or modified polysaccharide
polymers with anti-adhesive and bactericidal coatings has been reported to be a promising
means to fight against implant-associated biofilm infections(107).
Preliminary results support the hypothesis that NCIH of stainless steel and titanium
implants, is effective in reducing bacterial load of S. aureus within a biofilm in vitro. There was
a 20-fold decrease in CFU/ml after initial effect of thermal shock, and another 50-fold decrease
for the washers receiving both the heat and then the high dose vancomycin treatment for 24
hours.
This Dual treatment resulted in a ~1000-fold total decrease in CFUs compared to untreated
controls. (~ 3 log reduction). Combined effect of heat and use of antibiotics was seen, but complete
eradication was not observed. Since our planned set of experiments were delayed/interrupted due
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to restriction imposed due to COVID-19, we could not further test for different combinations
cocktails of antibiotics or different strains of Staphylococcus.
In conclusion non-contact induction heating of metallic (orthopedic) implants appears
feasible and was effective in vitro, in the reducing the bacterial load for S. aureus biofilm
Furthermore use of vancomycin, after the thermal shock showed a synergistic effect, leading to a
further decrease in bacterial load. But complete eradication was not observed.
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